Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.

Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q34644733
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients.GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.Inherited genetic variation in childhood acute lymphoblastic leukemia.The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemiaGeneral control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice.Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivoWhole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Advances in adult acute lymphoblastic leukemia therapy.Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity.Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides.Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
P2860

Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q34644733
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@ast
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@en
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@nl
type
label
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@ast
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@en
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@nl
prefLabel
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@ast
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@en
Polymorphisms of asparaginase ...... acute lymphoblastic leukemia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Polymorphisms of asparaginase ...... h acute lymphoblastic leukemia
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-14-0508
P407
P433
P478
P50
P577
P5875
P698
P921
P932